Pioneering Nutrition Therapy
Evolving innovative solutions for Nutrition Therapy to improve life has been a B. Braun commitment since the early sixties. Pioneering products like our infusible fat emulsions with either medium and long-chain triglycerides or additionally enriched with omega-3 fatty acids triglycerides and the convenient multi-chamber-bag system contributed decisively to advance Nutrition Therapy.
The latest milestone proving true innovative power was B. Braun Space GlucoseControl, which realizes reliable management of glucose levels in critically ill patients. Using it, the risk of hyperand hypoglycemia is reduced.1 With its intelligent dosage algorithm, B. Braun Space GlucoseControl integrates enteral and parenteral nutrition and exactly determines insulin rate and next sampling time – helping you to easily control complex work processes for a safe treatment in the ICU.
ICU patients may benefit from lipid emulsions enriched with omega-3 fatty acids drrived from fish oil
Reduced nosocomial infections2
The right choice of nutrients may have a tremendous effect on the recovery of patients. The study by Grau-Gramona showed, that ICU patients receiving parenteral nutrition enriched with omega-3 fatty acid triglycerides, face a significantly (p = 0.03) lower risk of nosocomial infections than patients receiving standard lipid emulsion.2
Reduced length of hospital stay3
Other clinical trials concluded that the treatment with lipid emulsions containing omega-3 fatty acids derived from fish oil, leads to improved lung function2 and reduced length of stay in the hospital, post-op.3
REFERENCES
1. Blaha et al. BMC Anesthesiology (2016) 16:8
2. Grau-Carmona T. et al. Crit Care Med 2015; 43: 31-39
3. Barbosa VM. et al. Crit Care 2010; 14(1): R5
4. Wichmann MW. et al. Crit Care Med 2007; 35(3): 700-6